Trastuzumab duocarmazine, CAS 1642152-40-6

Product Description: Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Gulden Menderes, et al. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression. Clin Cancer Res. 2017 Oct 1;23(19):5836-5845.

CAS Number: 1642152-40-6

Molecular Weight: 149000 (average)

Compound Purity: 99.87

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs)

• Artikelnummer: MEXHY-P99547-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99547-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK